必须从市场上消除假冒产品，并在政府、药企和公民团体间建立合作监管机制来控制质量。
Counterfeit products must be identified and removed from the marketplace, and a regulatory partnership between governments, the pharmaceutical sector, and citizens’ groups must be developed to control for quality.